Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples